07/15/05: Bernstein &Associates, Architects (www.bernarch.com) announces that a new article on usp 797 facility design has been published in Health Facilities Management.
Entitled "Pharmacy Facts: Architectural and Environmental Changes Required for USP 797", it was written by company principal William N. Bernstein, AIA. The article is a review of the 2005 usp 797 guideline, in terms of its impact on the design and construction of usp 797 compliant facilities.
For further information on design and construction of usp 797 compliant facilities, contact:
William N. Bernstein, AIA
Principal Bernstein &Associates, Architects - PLLC
59 West 19th Street - 6A New York, NY 10011
Office: 212.463.8200 Fax: 212.463.9898
Email: wb@bernarch.com http://www.bernarch.com/
This USP 797 pharmacy blog is focused exclusively on USP 797, a pharmacy-industry regulation which was developed by U.S. Pharmacopoeia. USP 797 was developed by USP to improve the methods of compounding sterile products, so as to increase patient safety and staff safety. For more information on USP, go to www.usp.org. For additional, privately-held resources regarding USP 797 ... go to: www.usp797.org ...connect on Facebook: www.facebook.com/usp797/ ... follow on Twitter: www.twitter.com/usp797.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment